Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kasraeian Urology is a private, family-owned urology practice in the Jacksonville, Florida area focused on diagnosis and treatment of prostate, bladder, kidney, and other genitourinary conditions in men and women. The practice is led by board-certified urologists Ahmad Kasraeian, MD, and Ali Kasraeian, MD, and emphasizes minimally invasive and technology-enabled urologic care. Its service offerings include prostate cancer treatment, benign prostatic hyperplasia care, overactive bladder management, kidney stone treatment, bladder cancer care, erectile dysfunction treatment, and urinary tract infection testing. The clinic markets advanced procedural capabilities such as HIFU, TULSA-PRO, AquaBeam Aquablation, UroLift, InterStim, extracorporeal shockwave lithotripsy, percutaneous nephrolithotomy, and low-intensity shockwave therapy. It appears to be a clinical care provider rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kasraeian Urology.